Comparative Study of 2 Anti-Dandruff shampoos, in patients with dandruff.
Not Applicable
Completed
- Conditions
- Health Condition 1: L21- Seborrheic dermatitis
- Registration Number
- CTRI/2021/07/035042
- Lead Sponsor
- upin Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 89
Inclusion Criteria
With clinical diagnosis of Dandruff or seborrheic dermatitis of the scalp.
Exclusion Criteria
Pregnancy by UPT or Lactating women
History or presence of compromising dermatosis elsewhere on the skin
Actinically damaged skin
Have used an antidandruff agent in the past 14 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in degree of scaling using a 4-point scaleTimepoint: Baseline, week 4 and week 12
- Secondary Outcome Measures
Name Time Method Change in degree of erythema using a 4-point scaleTimepoint: Baseline, week 4 and week 12;Change in degree of scalp itching using a 4-point scaleTimepoint: Baseline, week 4 and week 12;Clinical Examination of Scalp condition for in use tolerance with respect to drynessTimepoint: week 4 and week 12;Proportions of patients reporting recurrenceTimepoint: week 12;Subjective self-assessment questionnaire to assess participant perception of the in-use tolerance of productsTimepoint: week 4 and week 12;Subjective self-assessment questionnaire to assess patient perception of the efficacy of productsTimepoint: week 4 and week 12
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms differentiate anti-dandruff shampoos in CTRI/2021/07/035042 seborrheic dermatitis study?
How does CTRI/2021/07/035042 compare to standard-of-care treatments for L21 seborrheic dermatitis?
What biomarkers correlate with response to anti-dandruff shampoos in CTRI/2021/07/035042 trial?
What adverse events are associated with anti-dandruff shampoos in seborrheic dermatitis patients?
How do upin Ltd's anti-dandruff shampoos compare to competitor formulations in dandruff management?